Anticoagulation therapy associated with improved survival among COVID-19 patients
Early in the COVID-19 pandemic, Mount Sinai researchers were among the first to show that anticoagulation therapy was associated with improved survival among hospitalized COVID-19 patients
No hay comentarios:
Publicar un comentario